The estimated Net Worth of William H Mc Call is at least $1.99 millió dollars as of 10 May 2022. Mr. Call owns over 10,000 units of Sensus Healthcare Inc stock worth over $1,915,251 and over the last 8 years he sold SRTS stock worth over $75,400. In addition, he makes $0 as Non-Executive Independent Director at Sensus Healthcare Inc.
Sign up
Mr. McCall SRTS stock SEC Form 4 insiders trading
William has made over 1 trades of the Sensus Healthcare Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of SRTS stock worth $75,400 on 10 May 2022.
The largest trade he's ever made was selling 10,000 units of Sensus Healthcare Inc stock on 10 May 2022 worth over $75,400. On average, William trades about 2,000 units every 0 days since 2016. As of 10 May 2022 he still owns at least 325,723 units of Sensus Healthcare Inc stock.
You can see the complete history of Mr. Call stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William McCall biography
William McCall serves as Non-Executive Independent Director of the Company. Mr. McCall is currently Managing Director of Heritage Advisory Group, a financial advisory practice of Ameriprise Financial Services Inc., and has worked in such capacity since 2014. Mr. McCall also currently serves as Partner of Investors Capital Alliance LLC (since 2009), a consulting company; Chief Executive Officer of WMW Partners LLC (since 2009), an SEC-registered investment adviser; member of Pandora Mineral Resources LLC (since 2015); and Board member of Cherokee Farm Partners Inc. (since 2015), an entity of the University of Tennessee Research Foundation. Mr. McCall has a B.S. in business administration from the University of Tennessee and also earned his Chartered Wealth Advisor designation through the Michigan State University Estate and Wealth Management Institute. In light of Mr. McCall’s substantial experience as a financial advisor and portfolio manager for over 44 years, our Board believes that he is qualified to serve as a director.
How old is William McCall?
William McCall is 73, he's been the Non-Executive Independent Director of Sensus Healthcare Inc since 2015. There are no older and 15 younger executives at Sensus Healthcare Inc.
What's William McCall's mailing address?
William's mailing address filed with the SEC is 851 Broken Sound Pkwy NW #215, Boca Raton, FL 33487, USA.
Insiders trading at Sensus Healthcare Inc
Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen és Anthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.
What does Sensus Healthcare Inc do?
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
What does Sensus Healthcare Inc's logo look like?
Complete history of Mr. Call stock trades at Sensus Healthcare Inc
Sensus Healthcare Inc executives and stock owners
Sensus Healthcare Inc executives and other stock owners filed with the SEC include:
-
Stephen Cohen,
Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales -
Joseph C. Sardano,
Co-Founder, Chairman, CEO & Pres -
Joseph Sardano,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Stephen Cohen,
Co-Founder & Exec. VP -
Michael J. Sardano,
VP, Gen. Counsel & Corp. Sec. -
Kim Golodetz,
Investor Relations -
Samuel O'Rear,
Non-Executive Independent Director -
William McCall,
Non-Executive Independent Director -
John Heinrich,
Non-Executive Independent Director -
Anthony Petrelli,
Non-Employee Director -
Hoi-Bun Suen,
Vice President of International Sales -
Michael Sardano,
Vice President, General Counsel, Director of Governance and Regulatory -
James Price,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Dr. Clay Jefferies Cockerell,
Clinical Director & Member of Medical Advisory Board -
Dr. Mark S. Nestor,
Medical Director & Member of Medical Advisory Board -
Benson Suen,
VP of International Sales -
Yonatan Vainer,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Kalman Fishman,
CHIEF TECHNOLOGY OFFICER -
Richard Golin,
EXECUTIVE VICE PRESIDENT -
Arthur Levine,
CHIEF FINANCIAL OFFICER -
Megan Cornish,
-
Magdalena Martinez,
CHIEF OPERATING OFFICER